Navigation Links
Harlan Laboratories and BioXpert Announce Partnership to Expand Contract Breeding Services in Northern Europe

INDIANAPOLIS, Nov. 5, 2013 /PRNewswire/ -- Harlan Laboratories, a leading contract research organization and research models and services company, and BioXpert, a company specializing in laboratory animal science and services, today announced a partnership to expand Harlan Laboratories' Contract Breeding Services into Benelux, Northern Europe and Northern Germany. 

Through this partnership, Harlan Laboratories is able to provide the same services as from its UK and Southern Europe sites which include rederivation, cryopreservation, revitalization, colony management, contract breeding, health monitoring and quarantine services. As part of this strategic alliance, BioXpert will be able to support contract breeding and colony management in IVC, barrier, and isolator environments at its site in the Netherlands.

Founded by industry veterans, Tineke Coenen and Dr. Ir. Jan-Bas Prins, Ph.D., BioXpert's capabilities in in-vivo research provide the ideal alliance to expand Harlan Laboratories' contract breeding services. Together, the co-founders bring deep expertise in the areas of auto-immune models, oncology models, genetically modified models, surgically altered models, behavior studies and contract research.

"We have known and worked with Tineke Coenen, Founder and Managing Director of BioXpert, for a long time. BioXpert reflects her commitment to quality work, customer satisfaction, and animal welfare. We are both excited and proud to partner with BioXpert to expand our CBS offerings to the Benelux and Northern European countries," said Stuart Frith, Global Vice President Business Development, Harlan Laboratories. 

"We are thrilled to be working with Harlan Laboratories to bring contract breeding services to more customers in the region. The many similarities and synergies between the two companies made the decision to partner with Harlan a very easy one," added Coenen. "This partnership is a win for preclinical researchers in the Northern European region."

To get more information on Harlan Laboratories' Contract Breeding Services, please send a request to or visit  To learn more about Harlan Laboratories and BioXpert, please visit or

About Harlan Laboratories, Inc.
Harlan Laboratories, Inc. is a leading provider of essential, pre-clinical and non-clinical contract research, research models, animal diets, and services to the pharmaceutical, biotech, medical device, agrochemical and chemical industries, as well as universities, government, and other research organizations. Our focus is on providing customers with products and services to optimize the discovery and safety of new medicines and compounds. Harlan Laboratories is a privately held company.        

About BioXpert  
BioXpert provides colony management, advisory, and contract research services to the preclinical research market. Our services include full breeding programs, rederivation, cryo-banking, and transgenic services. We support the preclinical research process through services ranging from the provision of research models to conducting contract research in our facilities.  We deliver quality work to achieve quality results.  BioXpert is a privately held company.

Co-founder, Tineke Coenen holds a BSc in Microbiology, a BSc in Molecular Biology and Biochemistry, and a MSc in Lab Animal Sciences (FELASA D).  In addition to her academic and research expertise, Tineke has worked in the industry as a Senior Scientist, an Animal Welfare Officer and a Bio Safety Officer. Co-founder Dr. Ir. Jan-Bas Prins' PhD holds a masters degree in genetics, cell biology, and immunology.  In addition to his role within BioXpert, he currently serves as the Head of Animal Facilities at Leiden University Centre and is the current president of FELASA.

Michael Clark
Miller Brooks, Inc.

SOURCE Harlan Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. ARUP Laboratories Pathologist, Ronald L. Weiss, MD, Honored With Lifetime Achievement Award for Contributions to Patient Care and Pathology
2. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
3. EMD Millipore Partners with Charles River Laboratories for Improved Viral Clearance Studies
4. ARUP Laboratories Announces Creation of Business Innovations Division
5. MO BIO Laboratories, Inc. Launches the PowerMicrobiomeâ„¢ RNA Isolation Kit
6. Aviir Laboratories Announce National Agreement With MultiPlan
7. Aviir Laboratories Announce National Agreement with Three Rivers Provider Network
8. Aviir Laboratories Announce National Agreement with Stratose
9. Produce Safety Researchers Awarded by ABC Research Laboratories
10. Frost & Sullivan Presents 2012 Clinical Diagnostics Company of the Year Award to GenPath Diagnostics of BioReference Laboratories, Inc.
11. UAS Laboratories Presents about Probiotic Selection Criteria, at Scientific Conference
Post Your Comments:
(Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
(Date:11/25/2015)... San Francisco, CA (PRWEB) , ... November 25, ... ... leading microbial genomics company uBiome, were featured on AngelList early in their initial ... by launching an AngelList syndicate for individuals looking to make early stage investments ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology:
(Date:10/29/2015)...  The J. Craig Venter Institute (JCVI) policy group ... Biosecurity: Lessons Learned and Options for the Future," which ... Services guidance for synthetic biology providers has worked since ... --> --> Synthetic biology promises great ... pose unique biosecurity threats. It now is easier than ...
(Date:10/29/2015)... , Oct. 29, 2015 Today, ... a partnership with 2XU, a global leader in ... a smart hat with advanced bio-sensing technology. The ... athletes to monitor key biometrics to improve overall ... partnership, the two companies will bring together the most ...
(Date:10/26/2015)... and LAS VEGAS , Oct. 26, ... , an innovator in modern authentication and a founding ... the launch of its latest version of the Nok ... organizations to use standards-based authentication that supports existing and ... Authentication Suite is ideal for organizations deploying customer-facing applications ...
Breaking Biology News(10 mins):